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Background: In the past decade, several countries have seen gradual replacement of endemic multi-resistant
healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) with clones that are more susceptible to
antibiotic treatment. One example is Singapore, where MRSA ST239, the dominant clone since molecular profiling
of MRSA began in the mid-1980s, has been replaced by ST22 isolates belonging to EMRSA-15, a recently emerged
pandemic lineage originating from Europe.
Results: We investigated the population structure of MRSA in Singaporean hospitals spanning three decades, using
whole genome sequencing. Applying Bayesian phylogenetic methods we report that prior to the introduction of
ST22, the ST239 MRSA population in Singapore originated from multiple introductions from the surrounding region;
it was frequently transferred within the healthcare system resulting in a heterogeneous hospital population.
Following the introduction of ST22 around the beginning of the millennium, this clone spread rapidly through
Singaporean hospitals, supplanting the endemic ST239 population. Coalescent analysis revealed that although the
genetic diversity of ST239 initially decreased as ST22 became more dominant, from 2007 onwards the genetic
diversity of ST239 began to increase once more, which was not associated with the emergence of a sub-clone of
ST239. Comparative genomic analysis of the accessory genome of the extant ST239 population identified that the
Arginine Catabolic Mobile Element arose multiple times, thereby introducing genes associated with enhanced skin
colonization into this population.
Conclusions: Our results clearly demonstrate that, alongside clinical practice and antibiotic usage, competition
between clones also has an important role in driving the evolution of nosocomial pathogen populations.Background
The emergence and spread of bacterial pathogens that
have become adapted for survival in hospitals poses a
major threat to global health systems. One of the most
prevalent organisms causing healthcare-associated infec-
tions is Staphylococcus aureus [1]. This organism is part
of the natural microbiota of humans, from which clones
of epidemic drug-resistant S. aureus have emerged. First
described in 1961 within a year of the introduction of
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(HA-MRSA) have spread worldwide. Although there
is ongoing debate as to whether MRSA is associated
with increased mortality compared with its methicillin-
susceptible counterpart (HA-MSSA), HA-MRSA infec-
tions result in longer hospital stays and higher economic
costs, and impact on other resources such as isolation
facilities and bed management [3-5].
HA-MRSA was first isolated in hospitals in Singapore
in the late 1970s. This was followed in the early 1990s
by a sharp increase in prevalence, reaching a plateau in
the late 1990s when approximately 40% of S. aureus iso-
lated from inpatients with S. aureus infections were
MRSA [6]. In 2006, a total of 3,517 non-duplicate MRSA
isolates were cultured from clinical samples (497 from
blood) from the 6 public sector hospitals in Singaporeis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(Singapore General Hospital and Tan Tock Seng Hospital),
initiated MRSA-directed infection control programs from
2006, and the prevalence of MRSA in local hospitals
started to drop from 2008 [8].
Prior to 2000, most Singaporean MRSA isolates were
multilocus sequence type (MLST) 239 (ST239), which
possessed a type III staphylococcal cassette chromosome
element carrying the methicillin resistance determinant
gene mecA (SCCmec), and corresponded to the Hungarian
pandemic clone [6,9]. Starting in the early 2000s, however,
sequence type 22 (ST22) increased in prevalence to be-
come the dominant lineage in Singaporean hospitals. The
ST22 isolates belonged to epidemic MRSA (EMRSA)-15,
a HA-MRSA clone that emerged in the UK in the mid
1980s [10], and then became endemic in UK hospitals,
and subsequently spread internationally throughout
Europe and beyond to Australasia. The success of
EMRSA-15 is in part due to its inherent resistance to
fluoroquinolones associated with an increasing and
widespread use of this antibiotic class from the early
1990s onwards, and to its physiological characteristics.
In vitro studies indicate that EMRSA-15 is a fit clone
relative to other HA-MRSA (including ST239), with a
higher growth rate and resistance to desiccation [11],
although the genetic basis for these characteristics is
unknown.
Molecular epidemiology has demonstrated that the
global spread of MRSA has primarily been associated
with waves of epidemic MRSA clones [12], and that the
MRSA populations across geographical regions are in
flux over time [13]. Improving our understanding of
MRSA population dynamics, and the evolutionary forces
that drive this, is crucial for anticipating and combating
current and future threats posed by MRSA and other
pathogenic bacteria.
Using whole genome sequencing (WGS) we have
examined the population structure of MRSA during a
period of lineage replacement in Singapore, and investi-
gated the genomes of competing clones for evidence of
selection and subsequent evolutionary change.
Results
Molecular epidemiology of MRSA in Singapore
At the time of the study, Singapore had a population of
over 5 million people served by six acute care public sec-
tor hospitals. This study focused on MRSA collected bet-
ween 2000 and 2010 from the three main general
hospitals: Singapore General Hospital, Tan Tock Seng
Hospital and Changi General Hospital, which will subse-
quently be referred to as Hospital 1, Hospital 2 and
Hospital 3, respectively (Figure S1A in Additional file 1).
During this period all of the hospitals experienced a re-
placement of the MRSA clones associated with clinicalinfection. Early indications of distinct MRSA populations
were based on observed differences in antibiotic resist-
ance profiles; a clone resistant to multiple antibiotics
(including trimethoprim-sulfamethoxazole, gentamicin,
tetracycline, erythromycin with either inducible or consti-
tutive resistance to clindamycin, and fluoroquinolones) [6]
was being replaced by a clone resistant to fewer antibiotics
(erythromycin with inducible resistance to clindamycin,
and fluoroquinolones). Molecular typing using MLST con-
firmed the presence of two MRSA clones, and showed
that clonal replacement of ST239 by ST22 was occurring.
In Hospital 1, the first appearance of ST22 was in 2002,
followed by a rise in incidence over the following years
such that by 2010 it had become dominant (Figure 1).
MLST and other common molecular typing techniques
used to distinguish S. aureus lacked the resolution to in-
vestigate the fine-scale epidemiological changes occur-
ring in the population. To establish an accurate MRSA
population structure in Singapore, we sequenced the
whole genomes of 205 randomly selected clinical isolates
(Figure S1B in Additional file 1) from 2000 to 2010.
Hospitals 2 and 3 randomly selected five to six MRSA
isolates each year from a systematic collection of all
bacteremia isolates, which was established in 2001 and
2004, respectively. Hospital 1 stored a proportion of
MRSA associated with clinical infection each year since
2000, from which isolates were randomly selected from
each year. To provide historical genetic context we also
sequenced the genomes of all stored and available
MRSA isolated in the 1980s (n = 10) and 1990s (n = 28)
from Hospital 1 (SGH), the only hospital of the study hos-
pitals to have a historic collection of MRSA for the pre-
ceding two decades. To further supplement the historic
collection, 17 isolates from a fourth hospital (the National
University Hospital; Hospital 4) from 1997 were also
sequenced. This fourth hospital was formed in 1985 as an
offshoot of Hospital 1, taking with it some of its members
of staff and patients.
The 205 isolates from 2000 to 2010 were assigned
using sequence data to five MLST sequence types
(ST239, ST22, ST78, ST45 and ST5; Figure S1B in
Additional file 1; Additional file 2), although the majority
were ST239 (n = 110; 54.4%) followed by ST22 (n = 87;
42.6%). Six ST45 strains were isolated in 2009 and 2010
(Additional file 2), and single ST78 and ST5 strains were
both isolated in 2004. Analysis of historical isolates from
the 1980s and 1990s also revealed a predominance of
ST239; all isolates (n = 50) were ST239, with the excep-
tion of the very earliest isolates that were ST8 (n = 5).
Notably, no other ST8 isolates were identified in the
study after 1982. The first ST22 isolates were found
within the sample from Hospital 1 in 2003, after which
ST22 increased in prevalence and spread to other hospi-
tals (Figure S1B in Additional file 1). Correspondingly,
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Figure 1 Incidence of MRSA infections in Singapore General Hospital (Hospital 1) from 1997 to 2010 caused by ST22 and ST239.
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creased from 2003 onwards.
Phylogenetic reconstruction of the ST239 and ST22
populations
Genome sequence data were used to generate phylo-
genies based on core single nucleotide polymorphisms
(SNPs) for ST239 and ST22. Preliminary phylogenetic
analysis revealed that two isolates in the ST22 phylo-
genies were found on very long branches in comparison
to contemporaneous isolates (isolates B11318/05 and
DB055850/09). Both of these isolates were obtained from
blood cultures, and a review of the clinical records re-
vealed that they were obtained from patients who had
been heavily treated with antibiotics for persistent HA-
MRSA infection. Neither of the patients had received
treatment in an overseas hospital nor had any significant
travel history of note, suggesting that greater diversity of
the isolates was not likely to be the result of the import-
ation of a genetically divergent strain. Analysis of the ge-
nomes of these isolates revealed a deletion of a single
guanine residue within the DNA repair gene radA for
DB055850/09, resulting in a frame-shift mutation, and in
isolate B11318/05 a non-synonymous SNP was found in
the mutS gene encoding a DNA mismatch repair pro-
tein. It is likely that these mutations occurred during
prolonged antibiotic pressure, resulting in these isolates
becoming hyper-mutators. As a result these were ex-
cluded from the subsequent temporal analysis.
Bayesian phylogenetic reconstruction was used to ex-
plore the population structure and temporal spread of
the two major Singaporean MRSA clones (Figure 2;
Additional file 3). Comparison of the two phylogeniesshowed that the Singaporean ST239 exhibited a greater
overall phylogenetic diversity than Singaporean ST22
(Figure 2), consistent with the larger temporal spread of
the ST239 isolates. Examination of the ST239 population
revealed that the oldest isolates in the collection from
the 1980s and 1990s shared a common ancestor dating
back to approximately 1964 (Figure 2A; 95% highest
posterior density [HPD], 1951 to 1974), around the time
of the most recent common ancestor (tMRCA) of the
ST239 lineage (tMRCA mid 1960s) [14]. The majority of
ST239 isolates from 2000 to 2010 originated from a
single lineage that emerged in approximately 1994, and
subdivided into three distinct clades shortly after (indi-
cated as clades A, B and C in Figure 2A). In comparison,
the ST22 population was predicted to have a tMRCA of
July 2001 (Figure 2B; 95% HPD, June 2000 to April 2002),
which is contemporaneous with the first epidemiological
description of ST22 in Singapore in 2002 [7,15].
During the early to mid-2000s, shortly after the intro-
duction of ST22 into Singapore, the ST239 population
was composed of isolates that belonged to the three
main sub-clades (colored in Figure 2A) and also some
more distantly related isolates, possibly remnants of the
early Singaporean ST239 MRSA population, or imports
into Singapore from a related population in the sur-
rounding region (Figure 2A). As the ST22 population
became increasingly well established, there was a shift in
the ST239 population such that by the end our study
period, only isolates belonging to two of the three sub-
clades were sampled.
In both the ST239 and ST22 phylogenetic trees, isolates
from different hospitals were intermingled, indicating that
frequent exchanges had occurred between hospitals. This
Date
20102000199019801970
20102000199019801970
A
Date
20102000 2005
20102000 2005
B
 
Hospital 1 
Hospital 2 
Hospital 3 
Hospital 4 
A 
B 
C 
Figure 2 Temporal distribution of Singaporean ST239 and ST22 populations. (AB,) Maximum clade credibility tree of the ST239 (A) and ST22 (B)
populations based on BEAST analysis. Tips of the tree are constrained by isolation dates; the time scale is shown below the tree. The three colored
boxes in the ST239 tree represent the three main ST239 clades present during the study period of 2000 to 2010, clades A, B and C. Isolates that were
identified as potential hyper-mutators (Figure 3) were not included in the BEAST analysis. The mutation rate for the ST22 population was calculated as
1.4 × 10-6 mutations per year (95% HPD, 1.27 × 10-6 to 1.65 × 10-6), which was similar to the previously published rate for ST22 [10]. The estimated
mutation rate for ST239 of 2.2 × 10-6 mutations per year (95% HPD, 1.96 × 10-6 to 2.51 × 10-6) was slower than the previous estimate of Harris et al. [14],
but probably reflects the more sophisticated analysis method used in this study and also a more extensive data set. The colored balls on the tips of
the tree indicate the origins of the isolate (see legend to figure). For an illustration of the posterior support of the trees see Additional file 3.
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hospital transfer of patients and medical staff, which
occurred throughout the study period. An exception to
this genetic dispersal was noted for ST239 isolates from
Hospital 3, which with one exception all belonged to a
single sub-clade of the ST239 population (Figure 2A).
This clustering contrasted with the ST22 from this hos-
pital, which were distributed throughout the phylogen-
etic tree (Figure 2B).
Singaporean isolates in a global context
We next placed the Singaporean isolates into a global gen-
etic context by expanding both datasets with genomes
from global isolate collections sequenced and used pre-
viously to reconstruct the origins of both lineages
(Figure 3) [10,14,16]. This demonstrated that all of theST22 isolates from Singapore belonged to EMRSA-15
(Figure 3B), a healthcare-associated MRSA first identi-
fied in 1991, and originally defined by phage typing [10].
Recent phylogenomic analysis of a global collection of
ST22 revealed that the pandemic clone of EMRSA-15
emerged in the UK in the late 1980s, and quickly spread
throughout the UK and beyond [10]. Examining the
Singapore isolates in the context of a global collection
of ST22 isolates that correspond to the EMRSA-15 pan-
demic population (referred to as ST22-A2 by Holden et al.
[10]) showed that they all emanated from a single ances-
tral node, consistent with the single introduction of
ST22 into Singapore, followed by clonal expansion. The
isolate immediately ancestral to the Singaporean ST22
clade was isolated in the UK, suggesting a possible ori-
gin for this introduction.
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Figure 3 Global context of Singaporean ST22 and ST239 MRSA populations. (A,B) Unrooted maximum likelihood trees of Singaporean ST239 (A)
and ST22 (B) isolates including additional isolates representative of the global population of these two lineages. The ST239 phylogeny includes
the isolates described by Harris et al. [14] and Castillo-Ramirez et al. [16], and the ST22 phylogeny contains the isolates described by Holden et al.
[10]. In the case of ST22, only ST22-A isolates were included as these are representative of EMRSA-15, the clone from which the Singaporean ST22
isolates emerged. Trees were built using a maximum likelihood method using SNPs from the core genome, where the ST22 isolate reads were
mapped to the reference chromosome of HO 5096 0412 [20], and the ST239 isolate reads mapped to the TW20 [14] reference chromosome. Branches
are colored according to their geographical origins (see legend). The scale bar represents substitutions per SNP site for both trees. The two ST22
isolates excluded from the Bayesian analysis as potential hyper-mutators (B11318/05 and DB055850/09) are marked on the figure by asterisks.
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terspersed with isolates from other regions (Figure 3A).
The main clade containing Singaporean isolates also
contained two European isolates (UK and Demark)
together with other Asian isolates from Thailand and
China, suggesting several transmissions to and from
Singapore over the 28-year sampling timeframe. One of
the European isolates in the Singapore clade was TW20,
which was isolated in October 2003 as part of an out-
break on an ICU in a London hospital [17]. A previous
study of a global collection of ST239 genomes found
that TW20 clustered most closely with isolates from
Thailand (85 SNPs to the last common ancestor with a
Thai isolate) [14], and it was speculated that TW20 was
carried to the UK through intercontinental transmission
from Asia. Based on the genetic relatedness of TW20 to
the Singaporean isolates (22 SNPs to the last common
ancestor with a Singaporean isolate, 4045-41), and thetMRCA of TW20 and the Singaporean isolates of 21st
October 2002 (95% HPD 26th April 2001 to 3rd December
2003), it is possible that, within Asia, the origin of this
transmission is closer to Singapore than Thailand.
Competition between MRSA lineages generated selection
that has shaped the ST239 population structure
The topologies of the phylogenetic trees belonging to
the two clones were very distinct. The ST22 tree was
composed of branches that radiated out from a central
node to produce a star-like phylogeny, whereas the
ST239 population had more unbalanced phylogeny.
These features suggested that selection has acted diffe-
rentially on the two populations, and that in the case of
ST239 the population had experienced some form of
directional selection. Based on the differences in the
phylogenies, we hypothesized that competition between
ST22 and ST239 for the common niches within
Hsu et al. Genome Biology  (2015) 16:81 Page 6 of 13hospitals had resulted in selection, which led to differen-
tial effects on the two populations. In order to look in
more detail at the evolutionary impact, we conducted
demographic analysis on the ST239 and ST22 popu-AC
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Figure 4 Emergence of ACME-containing ST239 variants in the ST239 pop
populations based on BEAST analysis. Branches containing ACME-containin
represent the three main ST239 clades. (B) Skyline plot representing the effecti
in the grey shading represents ST239, and the line in the red shading represenlations (Figure 4). Bayesian skyline analysis [18] provided
an estimate of the genetic diversity of the ST239 and
ST22 populations. The success of ST22 following its
introduction into Singapore was associated with anME carrying ST239  
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ulation. (A) Maximum clade credibility tree of the 2000 to 2010 ST239
g isolates are colored red. The three colored boxes in the ST239 tree
ve genetic diversity of the ST239 and ST22 populations over time. The line
ts ST22, with the shaded areas representing 95% confidence intervals.
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2002 until 2004, after which this plateaued. During the
same period, the genetic diversity of the ST239 popula-
tion started to decline. Around 2005, when the genetic
diversity of ST22 had stabilized, the genetic diversity of
ST239 continued to fall until 2007, when, surprisingly, it
rebounded and started to increase. At this point the
overall clinical prevalence of ST239 in comparison to
ST22 in Singapore was falling, and therefore the appa-
rent increase in genetic diversity was likely due to the
emergence of successful subpopulations of ST239.
Having observed the signature of an adaptive response
in the ST239 population, we conducted comparative
genomic analysis to investigate the genetic basis of the
apparent success. From the phylogeny it was clear that
no single ST239 sub-clone emerged at the time of the
increase in diversity (Figure 2); therefore, it was unlikely
that mutations in the core genome and clonal expansion
were responsible for the observed effect. We then exam-
ined the population for evidence of homologous recom-
bination that could be associated with an increase in
genetic diversity. This revealed that across the whole
ST239 population (isolates from 1988 to 2010) the rate
of homoplasy was low; 48 of the 4,349 core SNP sites
were homoplasic (1.1%), consistent with previous studies
examining ST239 [14]. Analysis of the ST239 chromo-
somal sequences identified 18 putative recombination
regions that corresponded to approximately 7 kb of the
chromosome (Additional file 4). However, the distribu-
tion of these regions displayed phylogenetic structure,
suggesting that, like the SNPs, recombination was not
contributing to the increase in genetic diversity.
A possible explanation for the observed increase in the
genetic diversity of the population was the emergence of
multiple ST239 variants, following the acquisition of mo-
bile genetic elements (MGEs). Analysis of the accessory
genome of the ST22 and ST239 populations revealed that,
for both lineages, the accessory genomes were relatively
stable (Figure 5A); the accessory regions of both the
reference genomes (TW20 and HO 5096 0412) were con-
served in the majority of isolates. Analysis of the ST22-
ST239 pan-genome revealed limited evidence of genetic
exchange between ST239 and ST22 populations. In both
of these lineages, the prophage component of the ge-
nomes appeared to be relatively conserved (Figure 5A;
ϕSa1(TW20) and ϕSPβ-like(TW20), and ϕSa2(HO 5096
0412) and ϕSa3(HO 5096 0412), from the ST239 and
ST22 reference genomes, respectively); however, we found
one of the ST239 isolates (352_06) had acquired a ϕSa2
(HO 5096 0412)-like phage, and one of the ST22 isolates
(491_05) had acquired a ϕSPβ-like(TW20) phage. This
later prophage encodes SasX, a cell wall-anchored surface
protein, which is important for colonization and patho-
genicity and linked to the success of ST239 in Asia [19].In the case of the ST22 isolate 491_05, infection by the
ϕSPβ-like(TW20) phage has led to lysogenic conversion,
introducing the sasX into a genetic background where it
has previously been unseen. This observation highlights
the potential for co-circulating lineages of S. aureus to ex-
change phage and transfer virulence determinants across
the population, thereby generating new variants of epi-
demic clones shaped to the competing population.
The most widely exchanged MGE between the two
clones was a small plasmid encoding erythromycin re-
sistance which had been acquired by ST239 isolates. In
ST239, erythromycin resistance is typically encoded by
an ermA Tn554 transposon associated with the SCCmer
element [14]; in our collection, 100% of the ST239 iso-
lates contained ermA. In contrast, erythromycin resist-
ance in ST22 is frequently mediated by ermC encoded
on a small 2.4-kb plasmid [10,20]; in our collection, 84%
of the ST22 isolates contained ermC. Analysis of the
accessory genomes of the ST239 isolates revealed that
10 isolates (6%) had augmented their resistome by ac-
quiring the ermC plasmid (Figure 5A), to add to the
ermA they already possessed in their chromosomes.
Independent evolution of new variants of ST239 carrying
the ACME
One of the most abundant novel MGEs in the ST22-
ST239 pan-genome (that is, an MGE not present in the
reference genomes) was an approximately 12 kb fragment
in the ST239 isolates (Figure 5A) that encodes a type II
arginine catabolic mobile element (ACME-II; arc+ opp-3-;
Figure 5B) [21]; 14 isolates were identified which con-
tained ACME-II. Comparative genomic analysis of the
ST239 isolates from the period when the genetic diversity
of the population increased (2006 to 2010), with isolates
from earlier in the decade (2000 to 2005), identified that
the later isolates were more likely to contain the ACME-II
compared with those from the preceding 6 years (28.9%
versus 1.5%, respectively). The earliest ST239 strain in the
collection that contained an ACME region was isolated
from Hospital 1 in 2001 (DB014329/01). This strain was
found outside the three main Singaporean ST239 sub-
clades, and from the global population context it was most
closely related to isolates from Australia and North
America.
In contrast, the phylogenetic position of the ACME-
positive isolates from 2006 to 2010 indicated that these
isolates originated from the Singaporean ST239 popula-
tion (Figure 4A). Parsimony analysis suggested that there
had been a number of potential acquisition events of
ACME during this period rather than the expansion of a
single clone (Additional file 5). ACME elements were
detected in isolates belonging to two of the three ST239
sub-clades. In sub-clade B ACME were present in iso-
lates 097_08 and TTSH1_10, which shared the same
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Figure 5 Comparison of the accessory genomes of ST239 and ST22. (A) The presence and absence, by mapping, of components of the
accessory genomes of the Singaporean ST239 and ST22 isolates is shown in the panel on the right. For the figure, the colors of the blocks
represent percentage identity, going from white, indicating absence or less than 90% identity, through to red (via purple), indicating 100%
identity. Contigs of the combined accessory genomes are displayed as a pseudomolecule at the top of the panel, and are colored according to
the type of MGE (see legend to figure) they belong to, based on contig annotation and also comparison with an MGE reference set. The contigs
are ordered from left to right to compile MGEs from the ST239 reference (TW20), and then the ST22 reference (HO 5096 0412) chromosomes
(in the order they appear in the chromosome), then additional accessory genome components (in the order of large to small size). Text above
the contigs indicates the reference MGE name, or the name of the accessory elements where found. Isolates are ordered according to the
maximum likelihood trees displayed on the left; ST239 isolates are displayed at the top, and ST22 isolates at the bottom. Colored balls on the tips
of the tree indicate the origins of the isolate (see Figure 2 for legend). (B) Gene organization of the type II arginine catabolic mobile element
identified in the ST239 pan-genome. Coding sequences, indicated by arrows, are colored according to functional groups: pink, transposition; blue,
regulation; magenta, catabolism; green, hypothetical protein.
Hsu et al. Genome Biology  (2015) 16:81 Page 8 of 13phylogenetic node on the tree. Comparative analysis of
their ACME regions revealed that the DNA upstream
flanking the elements was distinct (Additional file 2).
Additionally, we also found that the ACME regions in
these two isolates were distinguished by a SNP (in097_08 there was a SNP in the intragenic region 81 bp
upstream of the arcR translational start site), suggesting
that although the isolates were phylogenetically linked,
they may have acquired separate ACME elements. The
only other variation in the ACME regions was found in
Hsu et al. Genome Biology  (2015) 16:81 Page 9 of 13the sub-clade C isolates. The ACME of four of the iso-
lates (CGH4_10, CGH6_06, 158_08 and 006_10) con-
tained a single base deletion in a poly-T octomer 592 bp
upstream of the arcR translational start. All of these iso-
lates were phylogenetically linked, suggesting a common
ancestry for this ACME element variant. The rest of the
ACME regions in the sub-clade C isolates were identical
and interleaved in the phylogeny with isolates that
lacked the element (Figure 4A). From the data it is not
possible to identify if the ACME distribution in sub-
clade C was the result of multiple acquisitions, or the
result of a single acquisition and subsequent loss on
multiple occasions.
Discussion
Singapore has a well-developed and interconnected
healthcare system, and is an informative setting for
studying the population dynamics of HA-MRSA within
a resource-rich healthcare system. Phylogenetic analysis
of MRSA isolates from these hospitals over the decade
2000 to 2010 revealed the population structure and dy-
namics of endemic ST239, and imported ST22, and
allowed us to investigate the evolutionary events sur-
rounding clonal replacement. The distribution of isolates
from the three hospitals on phylogenetic trees of both
ST239 and ST22 is indicative of frequent exchange bet-
ween hospitals. A recent study in the USA of S. aureus
from sterile-site infections in patients in four connected
hospitals in the Houston metropolitan area demon-
strated a similar exchange of isolates [22]. There was
some indication of decreased heterogeneity of ST239 in
Hospital 3, but this was not evident for ST22 in the
same hospital. This may reflect sampling bias since
fewer ST239 isolates were available from this hospital
compared with ST22, or may be due to differences in
the relative referral networks between hospitals. The
absence of strong hospital structuring for the MRSA
population is consistent with the healthcare model in
Singapore, where inter-hospital transfer of patients is
common and doctors rotate through different hospitals
throughout their training. The results indicate that, in
an interlinked hospital healthcare system, MRSA control
at one hospital may be compromised due to frequent
importation from elsewhere, and requires a unified sys-
tem of infection control across the different healthcare
providers.
The temporal reconstruction of the ST239 population
based on the genome data is consistent with the histor-
ical epidemiology of ST239 and other MRSA clones in
Singapore. Although the numbers were very small, five of
six MRSA isolates cultured in 1982 were ST8 (Figure 1B
in Additional file 1), suggesting that ST239 may have re-
placed ST8 in Singaporean hospitals during the early
1980s; however, as the relevant collection no longer exists,it is not possible to elucidate further the very early clone
dynamics of MRSA in Singapore.
The work of Holden et al. [10], and the data presented
in this study, provides strong evidence that the ST22
epidemic in Singapore was the result of a single in-
troduction, possibly from the UK, in 2001. This date is
concordant with the first appearance of the antibiotic sus-
ceptibility phenotype associated with ST22 in Singapore.
Intriguingly our analysis provides evidence that Singapore
may have been involved in an intercontinental transmission
in the other direction at about the same time. The cluster-
ing of the TW20 isolate within the Singapore clade suggests
SE Asia as the reservoir of TW20 and the associated
London hospital outbreak. Notably the Bayesian estimates
of the tMRCA of TW20 and the Singapore population was
October 2002. TW20 was originally isolated on the 21st of
October 2003, approximately a year after the predicted
tMRCA, although the outbreak that TW20 was part of
was demonstrated by molecular typing to have started
in October 2002. Taken together, the epidemiological
and phylogenomic evidence make a convincing case for
the direct transmission of TW20 lineage from Singapore
to London, leading to the establishment of the outbreak in
the hospital shortly after.
A limitation of the sampling framework used as the
basis for the study is that the isolates sequenced in this
study comprise just approximately 0.5% of all MRSA iso-
lated in Singapore over the study time period. In par-
ticular, pre-1999 ST239 isolates were not systematically
collected and sampled in the same fashion as the post-
1999 ST239 and ST22 isolates. This sampling bias may
have generated inexact estimations of the evolutionary
paths of both clones. Equally, only isolates from four of
six public sector hospitals had been stored and were
available to us. However, it is unlikely that the results for
the missing hospitals would be significantly different,
given similar traffic of patients and healthcare providers
and comparable prevalence of MRSA infections [8]. We
propose, therefore, that our sampling provided a repre-
sentative perspective of the national picture.
ST239 and ST22 are two of the most successful
hospital-adapted clones of S. aureus globally. In Singapore
during the study period these clones were in direct com-
petition for the same niche in humans and the hospital
environment, which gives rise to questions over the
biological basis for succession. There are several plausible
explanations for the success of any given nosocomial
pathogen. One is antibiotic resistance, but ST22 is more
antibiotic-susceptible than ST239, suggesting that resis-
tance to non-β-lactam and non-fluoroquinolone antibi-
otics was not crucial for its success. The ability to persist
in the hospital environment is facilitated by resistance to
antiseptics [23]. Notably there was a high level of carriage
of antiseptic resistance genes in ST239 (91% of the ST239
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lacked antiseptic resistance (none of the ST22 isolates
contained qacA/B; Additional file 2). Rather than resist-
ance, the key to the success of ST22 may reside in the in-
nate physiological properties of this clone. A role for
differential growth rate in the success of ST22 is sup-
ported by evidence from Knight et al. [11], who demon-
strated in vitro that ST22 (EMRSA-15) isolates had a
shorter lag phase and a higher growth rate than ST239
isolates, and also isolates from clonal complex 30 (CC30),
which were representatives of EMRSA-16, another suc-
cessful hospital-adapted epidemic clone. Mirroring the
ST239 clone replacement in Singapore, EMRSA-16
emerged in the UK approximately 10 years prior to
EMRSA-15 [24], and was the dominant MRSA clone in
the UK at the turn of the millennium, before declining in
incidence and being replaced by EMRSA-15 [25]. Co-
culture experiments by Knight et al. [11] demonstrated
that ST22 out-competed CC30. Additionally, they showed
that ST22 survived desiccation better than CC30, suggest-
ing that it was better adapted to surviving outside the
host, thus promoting transmission.
The comparative genomic analysis of the ST239 popu-
lation performed during this study revealed that new
variants of ST239 emerged that had acquired the same
mobile cassette of genes, ACME-II, which encodes an
arginine-deiminase system (Arc). In the collection,
ACME-II was over-represented in ST239 isolates from
2006 onwards. Due to the limited variation in the ACME
element, it has not been possible to resolve the precise
evolutionary origins and dynamics of the ACME in
ST239, but our comparative analysis of the ACME
within the ST239 population framework provided strong
evidence that the ACME was acquired independently on
more than one occasion. These events were predicted to
have occurred at a time when the genetic diversity of the
ST239 population was declining in the face of com-
petition from the newly established ST22 population
(Figure 4).
ACME has been associated with the success of
USA300 CA-MRSA [26] and an ST239 clade in Sydney
[27]. It has been proposed that the ammonia produced
by the ACME-encoded Arc system in the aerobic envi-
ronment of the skin contributes to acid tolerance during
colonization and bacterial persistence [28]. Therefore, it
is plausible that acquisition of ACME has enhanced the
ability of ST239 to survive on the skin. Consequently,
we hypothesize that ACME may provide cells carrying it
with competitive advantage, and thus promoted the in-
creased prevalence and persistence of ACME-II-carrying
ST239 isolates in Singapore. The most recent epide-
miology of MRSA in Singapore would appear to support
this; a recent study reported that the proportion of
ACME-positive ST239 had risen to an average of 43.7%across all Singapore hospitals [29], suggesting that the
population trajectory of the ACME variant of the ST239
we uncovered from the MRSA population-wide genome
analysis is robust.
Notably, the type II ACME lacks a spermidine acetyl-
transferase (speG) that is found in the ACME-I as-
sociated with USA300 [21,26]. This enzyme acetylates
polyamines and has been hypothesized to be a major
contributor to ACME-I-mediated fitness in USA300,
both to detoxify spermine [28,30] and also in antibiotic
resistance, keratinocyte killing, and biofilm formation
[31]. Additionally, it has been hypothesized that speG
has an important role in detoxifying the byproducts of
arginine catabolism that are produced by the arc system
[28]. However, the absence of speG suggests that the arc
operon is sufficient without other components found on
other types of ACME to confer an advantage.
The genomic perspective of the MRSA clone replace-
ment in Singapore revealed by this study has highlighted
the tenacity of S. aureus as a hospital-adapted pathogen.
The history of MRSA is one punctuated by the repeated
emergence and spread of new clones, supplanting pre-
viously successful populations. In Singapore, this has
recently been manifested as the displacement of ST239,
the dominant MRSA over a number of decades, by
ST22, a physiologically fitter MRSA recently emerged
from Europe. Arguably these two clones respectively
represent the most successful historic and contemporary
HA-MRSA pandemic clones of all.
Conclusions
By examining the MRSA population structure over a
decade we have been able to chart the success of ST22
as it established its dominance, and demonstrate knock-
on effects on the declining endemic ST239 population,
as it is out-competed from its healthcare niche. Our re-
sults clearly demonstrate that, alongside clinical practice
and antibiotic usage, competition between clones also
has an important role in driving the evolution of noso-
comial pathogen populations.
Materials and methods
Bacterial isolates
MRSA isolates from the period 2000 to 2010 were ran-
domly obtained from the microbiology laboratories of three
public sector hospitals in Singapore (Additional file 6), with
each hospital contributing a number of isolates each year
that approximated to the relative prevalence of MRSA in-
fections among the hospitals. Isolates from Hospital 1 were
retrieved from a longstanding HA-MRSA collection (since
2000), whereas isolates from Hospitals 2 and 3 were from
blood culture collections that had been in existence since
2001 and 2003, respectively. Pre-2000 Singaporean MRSA
isolates were retrieved from the Gram-Positive Bacteria
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Western Australia, where they had previously been de-
posited in collaborative work with Hospital 1 and Hospital
4 - a university hospital that had been established in 1985,
with many existing staff and patients from Hospital 1. In
total 260 isolates were sequenced: 160 ST239, 87 ST22,
6 ST45, 5 ST8, 1 ST5 and 1 ST78.
Susceptibility to oxacillin, erythromycin, clindamycin,
ciprofloxacin, tetracycline, trimethoprim/sulfamethoxazole,
and gentamicin was determined using the Kirby-Bauer disk
diffusion method following standards established by the
Clinical Laboratory and Standards Institute (CLSI) [32].
The minimum inhibitory concentrations (MICs) of vanco-
mycin were determined via Etest (AB Biodisk, Solna,
Sweden), and screening for vancomycin-heteroresistant S.
aureus (hVISA) was performed on all isolates using Etest
GRD strips (AB Biodisk) in duplicate following the manu-
facturer’s guidelines. DNA was extracted from all isolates
using a commercial kit (DNeasy kit; Qiagen) according to
specifications required for WGS.
Tagged genomic library preparation and DNA sequencing
DNA libraries were created using a method adapted
from the Illumina Indexing standard protocol. In brief,
the steps taken (with clean-up between each step) were:
genomic DNA were fragmented by acoustic shearing to
enrich for 200 bp fragments using a Covaris E210, end-
repaired and A-tailed. Adapter ligation was followed by
overlap extension PCR using the Illumina 3 primer set
to introduce specific tag sequences between the sequen-
cing and flow-cell binding sites of the Illumina adapter.
After quantification by quantitative PCR followed by
normalization and pooling, pooled libraries were se-
quenced on Illumina GAII and HiSeq platforms ac-
cording to the manufacturer’s protocols generating index
tag-end sequences.
Multilocus sequence type assignment and SNP detection
MLST sequence types were identified from sequence
data as previously described [33]. Illumina reads were
mapped onto the relevant reference sequences using
SMALT [34]; TW20 (accession number FN433596) for
ST239 [14], and HO 5096 0412 (accession number
HE681097) genome for EMRSA-15 [20]. A minimum of
30× depth of coverage for more than 92% of the reference
genomes was achieved for both references (Additional file 2).
The default mapping parameters recommended for
reads were employed, but with the minimum score re-
quired for mapping increased to 30 to make the mapping
more conservative. Candidate SNPs were identified using
samtools mpileup [35], with SNPs filtered to remove those
at sites with a mapping depth less than five reads and a
SNP score below 60. SNPs at sites with heterogeneous
mappings were filtered out if the SNP is present in lessthan 75% of reads at that site [14]. Identification of the
core genomes was performed as previously described
[10,14]. Recombination was detected in the genomes
using Gubbins [36].
Phylogenetic analysis
Phylogenetic trees for ST239 and ST22 were constructed
separately using RAxML v.7.0.4 [37] for all sites in the
core genomes containing SNPs, using a generalised time
reversible (GTR) model with a gamma correction for
among-site rate variation [14].
We used the Bayesian software package BEAST (v.1.7.4)
[38] to investigate the temporal, spatial and demographic
evolution of the ST239 and ST22 populations. To estimate
the substitution rates and times for divergences of internal
nodes on the tree, a GTR model with a gamma correction
for among-site rate variation was used. All combinations
of strict, relaxed lognormal, relaxed exponential and ran-
dom clock models and constant, exponential, expansion,
logistic and skyline population models were evaluated. For
each, three independent chains were run for 100 million
generations, sampling every 10 generations. On comple-
tion each model was checked for convergence, both by
checking effective sample size (ESS) values were greater
than 200 for key parameters, and by checking independent
runs had converged on similar results. Models including
logistic population models failed to converge so were dis-
carded. Models were compared for their fit to the data
using Bayes factors based on the harmonic mean estima-
tor as calculated by the program Tracer v.1.4 from the
BEAST package. The best-fit model combination was
found to be a relaxed exponential clock model and a sky-
line population model, and so this combination was used
for all further analysis. A burn-in of 10 million states was
removed from each of the three independent runs of this
model before combining the results from those runs with
the logcombiner program from the BEAST package. A
maximum clade credibility (MCC) tree was created from
the resulting combined trees using the treeAnnotator pro-
gram, also from the BEAST package. Skyline plots [18] for
the ST239 and ST239 groups were constructed using the
skyline function of the ape library in R. Ancestral recon-
struction of ACME elements was conducted using the
Dendropy Python library [39].
De novo assembly and detection of the accessory genome
De novo assembly of genomes of all isolates was per-
formed using Velvet v.0.7.03 [40], with mobile genetic
elements detected as previously described [14]. In par-
ticular, the presence of antibiotic resistance genes and
mutations, virulence genes, and genetic elements such
as the ACME was screened for by comparison with gen-
etic sequences published on public sequence databases
and reviews [41,42].
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for all isolates were mapped against the HO 5096 0412
reference chromosome using the Nucmer algorithm in
MUMmer [43]. The core genome for the reference was
manually defined by identifying and removing all MGE
regions. For each isolate, regions of their assembly
greater than 1 kb which did not find a match in the ref-
erence chromosome were defined as accessory contigs.
These contigs, together with contigs created from the
mobile genetic elements identified in the reference gen-
ome, were then compared in a pairwise manner using
Nucmer. In each comparison, contigs were retained if
they contained at least 1 kb of unmatched sequence, or
if they were the longer of the two compared sequences.
Where two contigs were identical, one was kept at ran-
dom. All other contigs were discarded. Presence or ab-
sence of the resulting accessory genome was assessed for
each isolate by mapping their original assembly against
the reference core genome regions and accessory contigs
simultaneously using Nucmer. Automatic annotation of
the accessory genome contigs was carried out using
Prokka [44]. Detailed comparisons of individual sequences
was conducted on the de novo assemblies using BlastN
[45], and was facilitated by using the Artemis Comparison
Tool (ACT) [46].Data access
The Illumina sequences generated and used in this study
have been deposited in the European Nucleotide Archive
under the study accession number ERP000356.Additional files
Additional file 1: Figure S1. Temporal, geographical and clonal
distribution of Singaporean MRSA sequenced in this study. (A) Map of
Singapore indicating the location of the four hospitals contributing
isolates to this study. (B) Bar graph displays the number of MRSA isolates
sequenced over a year, and is broken down according to the hospital of
origin. For a given hospital, the columns are subdivided to display the
number of isolates of an individual sequence type (ST) that have been
sequenced.
Additional file 2: Table S1. Isolate metadata, including date and
hospital of isolation, mapping and assembly statistics, and genotype and
phenotype information.
Additional file 3: Figure S2. (A,B) Posterior support of maximum clade
credibility trees of the ST239 (A) and ST22 (B) populations based on
BEAST analysis (as illustrated in Figure 3). Internal branches are colored
according to their posterior support (see figure for key).
Additional file 4: Figure S3. Prediction of recombination in the ST239
isolate chromosomes. Regions of variation in the core genomes of ST239
isolates predicted to have arisen by homologous recombination in
comparison to the TW20 reference chromosome are shown in the panel
on the right. Red blocks indicate recombination predicted to have
occurred on internal nodes, blue indicates taxa-specific recombination).
Isolates are ordered according to the phylogenetic tree displayed on the
left. The track along the top of the figure displays the TW20 chromosome
and annotation, where protein coding sequences (CDSs) are indicated in
light blue. Where recombination is predicted to have occurred in a CDS,the locus tag of the CDS or CDS range affected is displayed in green text
above. The associated gene name, where available, is displayed in brackets.
Additional file 5: Figure S5. Parsimonious reconstruction of ACME
elements in the ST239 population comprising clades A, B and C. The
reconstruction of ACME elements was based on the binary presence or
absence using a delayed transformation (DELTRAN) method and a
maximum likelihood phylogeny. Accelerated transformation (ACCTRAN)
was also performed and gave an identical reconstruction.
Additional file 6: Table S2. Distribution of HA-MRSA isolates by year
and hospital of isolation, and sequence type.
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